Canada’s next big bet needs to be on medical isotopes

Cancer is still the leading cause of death in Canada. Industry is ready to deliver, and with government involvement, we can work together to bring hope to patients who face a bleak outcome.

Innovation Minister François-Philippe Champagne, pictured with Stephanie Diana Rädel, an accelerator physicist, toured TRIUMF’s Institute for Advanced Medical Isotopes in May 2023. The global market for medical isotopes is about to boom, write the authors.Photograph courtesy of TRIUMF

Opinion

BY MIKE RENCHECK, MICHAEL CHEGAHNO, KATHRYN HAYASHI, OWEN ROBERTS, DAVE TUCKER

July 27, 2023

Canada is on the cusp of an incredible opportunity: to be the world's leading supplier of medical isotopes and the cancer-fighting and cancer-finding therapies these isotopes make possible.

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy